New peanut allergy therapy shows 84 per cent success A new therapy for peanut allergy has been successful in the majority of the 99 children who took part in a trial conducted by researchers at Addenbrooke's Hospital in Cambridge, UK. ...
Tags: Peanut, allergy, peanut immunotherapy, enzyme
Dyadic International, Inc. , a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, ...
Tags: biotechnology
A simple adjustment to a powerful gene-editing tool may be able to improve its specificity.In a report receiving advance online publication in Nature Biotechnology,Massachusetts General Hospital(MGH)investigators describe how adjusting the ...
Teva Pharmaceutical Industries and Active Biotech have announced that both companies remain committed to the Nerventra(laquinimod)clinical development program for multiple sclerosis(MS)following the announcement of a negative opinion for ...
Tags: Medicine, clinical studies, Nerventra
With its new pilot plant,Mühlenchemie GmbH&Co.KG offers pasta manufacturers an additional service. At the pasta laboratory in Ahrensburg,customers can now verify the possible effects of enzymes and other additives on noodle products ...
Tags: Agriculture, Plant, Pasta
Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have ...
Tags: triple negative, Curie-Cancer, TTK/MPS1, Institut Curie and Servier
Omeros Corporation (NASDAQ: OMER) today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic ...
THURSDAY Jan. 23, 2014, 2014 -- Race and gender affect whether heart attack patients still take recommended medications a year later, a new study finds. And black and Hispanic women are least likely to continue using the drugs meant to ...
Tags: ACE, ARBs, heart attack, patient
Researchers at the Swiss Federal Institute of Technology in Zurich have deciphered the structure of part of the ribosome found in mitochondria, the power plants of the cell. The scientists were able to benefit from advancements in the field ...
Tags: Consumer Electronics, Electronics
Although vaccination against infectious disease is a routine component of horse care, many owners still voice concerns about their horse's risk of having an adverse reaction to these injections. For this reason, veterinarians sometimes ...
NEW YORK, Jan. 20 (UPI) -- New York researchers have identified a molecular mechanism by which cocaine alters the brain's reward circuits and causes addiction. Dr. Eric J. Nestler, director of the Friedman Brain Institute at the Icahn ...
Tags: molecular mechanism, PARP, ADP, drug
Back in the Middle Ages, Central Europeans were already capable of digesting milk, yoghurt and cheese just as well as us today. Researchers at the University of Zurich's Centre for Evolutionary Medicine have discovered that the population ...
Tags: Consumer Electronics, Electronics
What is ETMR/ETANTR and who does it affect? Embryonal tumours with multilayered rosettes (ETMR) are rare, deadly brain tumours that affect mainly children below the age of 4 years. There are 300 cases reported but probably there are many ...
A Virginia Tech research team has developed a battery that runs on sugar and has an unmatched energy density, a development that could replace conventional batteries with ones that are cheaper, refillable, and biodegradable. The findings ...
Tags: Consumer Electronics, Electronics
Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into ...